Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insight: Abbott’s Libre 3 Finds Route To NHS Patients With YpsoMed And CamDiab Partnership

Executive Summary

Abbott’s flagship CGM, the FreeStyle Libre 3, will soon become available in the UK through the National Health Service as part of a hybrid closed-loop system utilizing Ypsomed and CamDiab’s technologies.

You may also be interested in...



Abbott Partners With ADA On Nutrition Program

Abbott providing $2.65m to American Diabetes Association to study how continuous glucose monitoring systems can help people with diabetes improve their diet and exercise habits.

Minute Insight: Abbott Partners With ADA On Nutrition Program

Abbott is providing $2.65m to the American Diabetes Association to study how continuous glucose monitoring systems can help people with diabetes improve their diet and exercise habits.

Medtronic’s 780G – Finally! – Gets FDA Approval

Earlier than expected, but still after a more than three year wait, the company has obtained FDA approval for its flagship insulin delivery system.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147880

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel